Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells

Journal of Medical Virology

Volumn 80, Issue 3, 2008, Pages 373-382

  Hosoya, Noriaki ^a   Miura, Toshiyuki ^a   Kawana Tachikawa, Ai ^a   Koibuchi, Tomohiko ^a   Shioda, Tatsuo ^b   Odawara, Takashi ^a   Nakamura, Tetsuya ^a   Kitamura, Yoshihiro ^a   Kano, Munehide ^c   Kato, Atsushi ^c   Hasegawa, Mamoru ^d   Nagai, Yoshiyuki ^e   Iwamoto, Aikichi ^a,f,g  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d DNAVEC Research Inc   (Japan)

^e RIKEN YOKOHAMA INSTITUTE   (Japan)

^f INSTITUTE OF BIOPHYSICS   (China)

^g INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

AIDS; Immuno genetherapy; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; SENDAI VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOPLASM; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MONOCYTE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SENDAI VIRUS; T LYMPHOCYTE; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION;

ADENOVIRIDAE; AIDS VACCINES; ANIMALS; DENDRITIC CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; SENDAI VIRUS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; VACCINES, DNA;

ADENOVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; SENDAI VIRUS;

EID: 38849179471     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21052     Document Type: Article

References (49)

1. Agungpriyono DR, Yamaguchi R, Uchida K, Tohya Y, Kato A, Nagai Y, Asakawa M, Tateyama S. 2000. Green fluorescent protein gene insertion of Sendai Virus infection in nude mice: Possibility as an infection tracer. J Vet Med Sci 62:223-228.
2. Arrode G, Boccaccio C, Lule J, Allart S, Moinard N, Abastado JP, Alam A, Davrinche C. 2000. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J Virol 74:10018-10024.
3. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
4. Bitzer M, Prinz F, Bauer M, Spiegel M, Neubert WJ, Gregor M, Schulze-Osthoff K, Lauer U. 1999. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J Virol 73:702-708.
5. Bonini C, Lee SP, Riddell SR, Greenberg PD. 2001. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. J Immunol 166:5250-5257.
6. Brander C, Walker BD. 1999. T lymphocyte responses in HIV-1 infection: Implications for vaccine development. Curr Opin Immunol 11:451-459.
7. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. 1994. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272.
8. Diao J, Smythe JA, Smyth C, Rowe PB, Alexander IE. 1999. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lym-phocyte responses against a vector-encoded antigen in vitro. Gene Ther 6:845-853.
9. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J Immunol 163:6762-6768.
10. Engelmayer J, Larsson M, Lee A, Lee M, Cox WI, Steinman RM, Bhardwaj N. 2001. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals. J Virol 75:2142-2153.
11. Furutsuki T, Hosoya N, Kawana-Tachikawa A, Tomizawa M, Odawara T, Goto M, Kitamura Y, Nakamura T, Kelleher AD, Cooper DA, Iwamoto A. 2004. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population. J Virol 78:8437-8445.
12. Gorman WL, Gill DS, Scroggs RA, Portner A. 1990. The hemagglutinin- neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology 175:211-221.
13. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
14. Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ. 2000. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood 96:1857-1864.
15. Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. 1997. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J 16:2294-2306.
16. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR. 1996. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 70:4502-4508.
17. Ishii-Watabe A, Uchida E, Iwata A, Nagata R, Satoh K, Fan K, Murata M, Mizuguchi H, Kawasaki N, Kawanishi T, Yamaguchi T, Hayakawa T. 2003. Detection of replication-competent adeno-viruses spiked into recombinant adenovirus vector products by infectivity PCR. Mol Ther 8:1009-1016.
18. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. 1999. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189:991-998.
19. Kanegae Y, Makimura M, Saito I. 1994. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157-166.
20. Kano M, Matano T, Kato A, Nakamura H, Takeda A, Suzaki Y, Ami Y, Terao K, Nagai Y. 2002. Primary replication of a recombinant Sendai virus vector in macaques. J Gen Virol 83:1377-1386.
21. Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569-579.
22. Kato M, Igarashi H, Takeda A, Sasaki Y, Nakamura H, Kano M, Sata T, Iida A, Hasegawa M, Horie S, Higashihara E, Nagai Y, Matano T. 2005. Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expre-ssing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus. Vaccine 23:3166-3173.
23. Kawana-Tachikawa A, Tomizawa M, Nunoya J, Shioda T, Kato A, Nakayama EE, Nakamura T, Nagai Y, Iwamoto A. 2002. An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. J Virol 76: 11982-11988.
24. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97-105.
25. Larsson M, Fonteneau JF, Somersan S, Sanders C, Bickham K, Thomas EK, Mahnke K, Bhardwaj N. 2001. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol 31:3432-3442.
26. Levy JA, Cheng-Mayer C, Dina D, Luciw PA. 1986. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 232:998-1001.
27. Li HO, Zhu YF, Asakawa M, Kuma H, Hirata T, Ueda Y, Lee YS, Fukumura M, Iida A, Kato A, Nagai Y, Hasegawa M. 2000. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol 74:6564-6569.
28. Lipscomb MF, Masten BJ. 2002. Dendritic cells: Immune regulators in health and disease. Physiol Rev 82:97-130.
29. Lyn D, Gill DS, Scroggs RA, Portner A. 1991. The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J Gen Virol 72:983-987.
30. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72:164-169.
31. McMichael AJ, Rowland-Jones SL. 2001. Cellular immune responses to HIV. Nature 410:980-987.
32. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324.
33. Mizuguchi H, Hayakawa T. 2002. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 285:69-77.
34. Mwau M, Cebere I, Sutton J, Chikoti P, Winstone N, Wee EG, Beattie T, Chen YH, Dorrell L, McShane H, Schmidt C, Brooks M, Patel S, Roberts J, Conlon C, Rowland-Jones SL, Bwayo JJ, McMichael AJ, Hanke T. 2004. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: Stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol 85: 911-919.
35. Nagayama H, Sato K, Morishita M, Uchimaru K, Oyaizu N, Inazawa T, Yamasaki T, Enomoto M, Nakaoka T, Nakamura T, Maekawa T, Yamamoto A, Shimada S, Saida T, Kawakami Y, Asano S, Tani K, Takahashi TA, Yamashita N. 2003. Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. Melanoma Res 13:521-530.
36. Rea D, Schagen FH, Hoeben RC, Mehtali M, Havenga MJ, Toes RE, Melief CJ, Offringa R. 1999. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol 73:10245-10253.
37. Rouas R, Uch R, Cleuter Y, Jordier F, Bagnis C, Mannoni P, Lewalle P, Martiat P, Van den Broeke A. 2002. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: Optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9:715-724.
38. Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T, Yoshida T, Tanaka A, Hasegawa M, Nagai Y. 1999. Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication. FEBS Lett 456:221-226.
39. Smith FS, Portner A, Leggiadro RJ, Turner EV, Hurwitz JL. 1994. Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1. Virology 205:453-461.
40. Stockwin LH, Matzow T, Georgopoulos NT, Stanbridge LJ, Jones SV, Martin IG, Blair-Zajdel ME, Blair GE. 2002. Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J Immunol Methods 259:205-215.
41. Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC. 2001. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 7:625-629.
42. Tabi Z, Moutaftsi M, Borysiewicz LK. 2001. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J Immunol 166:5695-5703.
43. Takeda A, Igarashi H, Nakamura H, Kano M, Iida A, Hirata T, Hasegawa M, Nagai Y, Matano T. 2003. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol 77:9710-9715.
44. Tan PH, Beutelspacher SC, Xue SA, Wang YH, Mitchell P, McAlister JC, Larkin DF, McClure MO, Stauss HJ, Ritter MA, Lombardi G, George AJ. 2005. Modulation of human dendritic-cell function following transduction with viral vectors: Implications for gene therapy. Blood 105:3824-3832.
45. Tropea F, Troiano L, Monti D, Lovato E, Malorni W, Rainaldi G, Mattana P, Viscomi G, Ingletti MC, Portolani M, et al. 1995. Sendai virus and herpes virus type 1 induce apoptosis in human peripheral blood mononuclear cells. Exp Cell Res 218:63-70.
46. Tsunetsugu-Yokota Y, Morikawa Y, Isogai M, Kawana-Tachikawa A, Odawara T, Nakamura T, Grassi F, Autran B, Iwamoto A, 2003. Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs. J Virol 77:10250-10259.
47. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-2080.
48. Yang OO, Kalams SA, Trocha A, Cao H, Luster A, Johnson RP, Walker BD. 1997. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 71: 3120-3128.
49. Yu D, Shioda T, Kato A, Hasan MK, Sakai Y, Nagai Y. 1997. Sendai virus-based expression of HIV-1 gp120: Reinforcement by the V(-) version. Genes Cells 2:457-466.